The MLCK‐mediated α 1 ‐adrenergic inotropic effect in atrial myocardium is negatively modulated by PKC ɛ signaling
Open Access
- 1 August 2006
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 148 (7) , 991-1000
Abstract
The present study examined the role of myosin light chain kinase (MLCK), PKC isozymes, and inositol 1,4,5‐trisphosphate (IP 3 ) receptor in the positive inotropic effect of α 1 ‐adrenergic stimulation in atrial myocardium. We measured inotropic effects of phenylephrine (0.3–300 μ M ) in isolated left atrial preparations (1 Hz, 37°C, 1.8 m M Ca 2+ , 0.3 μ M nadolol) from male 8‐week FVB mice ( n =200). Phenylephrine concentration‐dependently increased force of contraction from 1.5±0.1 to 2.8±0.1 m N (mean±s.e.m., n =42), which was associated with increased MLC‐2a phosphorylation at serine 21 and 22 by 67% and translocation of PKC ɛ but not PKC α to membrane (+30%) and myofilament (+50%) fractions. MLCK inhibition using ML‐7 or wortmannin right‐shifted the concentration–response curve of phenylephrine, reducing its inotropic effect at 10 μ M by 73% and 81%, respectively. The compound KIE1‐1 (500 n M ), an intracellularly acting PKC ɛ translocation inhibitor peptide, prevented PKC ɛ translocation and augmented the maximal inotropic effect of phenylephrine by 40%. In contrast, inhibition of Ca 2+ ‐dependent PKC translocation (KIC1‐1, 500 n M ) had no effect. Chelerythrine, a PKC inhibitor, decreased basal force without changing the inotropic effect of phenylephrine. The IP 3 receptor blocker 2‐APB (2 and 20 μ M ) concentration‐dependently decreased basal force, but did not affect the concentration–response curve of phenylephrine. These results indicate that activation of MLCK is required for the positive inotropic effect of α 1 ‐adrenergic stimulation, that the Ca 2+ ‐independent PKC ɛ negatively modulates this effect, and that PKC α and IP 3 receptor activation is not involved. British Journal of Pharmacology (2006) 148 , 991–1000. doi: 10.1038/sj.bjp.0706803Keywords
This publication has 56 references indexed in Scilit:
- Modulation of myosin phosphatase targeting subunit and protein phosphatase 1 in the heartAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Protein kinase C ? and ? mediate positive inotropy in adult ventricular myocytesJournal of Molecular and Cellular Cardiology, 2005
- Key role of myosin light chain (MLC) kinase-mediated MLC2a phosphorylation in the ?-adrenergic positive inotropic effect in human atriumCardiovascular Research, 2005
- Biodistribution of intracellularly acting peptides conjugated reversibly to TatBiochemical and Biophysical Research Communications, 2004
- Diacylglycerol's affair with protein kinase C turns 25Trends in Pharmacological Sciences, 2004
- Mechanism of the negative inotropic effects of α1-adrenoceptor agonists on mouse myocardiumCanadian Journal of Physiology and Pharmacology, 2003
- Influence of left ventricular dysfunction on the role of atrial contractionJACC, 2000
- Xestospongin C, a selective and membrane‐permeable inhibitor of IP3 receptor, attenuates the positive inotropic effect of α‐adrenergic stimulation in guinea‐pig papillary muscleBritish Journal of Pharmacology, 2000
- In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the MouseScience, 1999
- Phosphorylation of Cardiac Myosin Light Chain 2 by Protein Kinase C and Myosin Light Chain Kinase Increases Ca2+-Stimulated Actomyosin MgATPase ActivityBiochemical and Biophysical Research Communications, 1993